-
公开(公告)号:US20060046986A1
公开(公告)日:2006-03-02
申请号:US11209234
申请日:2005-08-23
申请人: Donghong Gao , Neil Moss , Ji Wang , Jiang-Ping Wu , Lifen Wu , Zhaoming Xiong
发明人: Donghong Gao , Neil Moss , Ji Wang , Jiang-Ping Wu , Lifen Wu , Zhaoming Xiong
IPC分类号: A61K31/538 , A61K31/5377 , A61K31/52 , A61K31/519 , A61K31/501 , A61K31/496 , A61K31/4439
CPC分类号: C07D487/04 , C07D209/10 , C07D209/42 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/10 , C07D403/12 , C07D405/12 , C07D413/06 , C07D417/06 , C07D487/08
摘要: Disclosed are compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
-
公开(公告)号:US08609696B2
公开(公告)日:2013-12-17
申请号:US13139363
申请日:2009-12-14
申请人: Derek Cogan , Neil Moss , Christopher Ronald Sarko , Samantha Jayne Bamford , Pui Leng Loke , Heather Tye , Mark Whittaker
发明人: Derek Cogan , Neil Moss , Christopher Ronald Sarko , Samantha Jayne Bamford , Pui Leng Loke , Heather Tye , Mark Whittaker
IPC分类号: A61K31/445 , C07D401/04
CPC分类号: C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: Disclosed are Serotonin 5-HT2B receptor inhibitors of the formula I. Also disclosed are methods of making and methods of using these compounds.
摘要翻译: 公开了式I的5-羟色胺5-HT 2B受体抑制剂。还公开了制备方法和使用这些化合物的方法。
-
公开(公告)号:US20110269742A1
公开(公告)日:2011-11-03
申请号:US13139363
申请日:2009-12-14
申请人: Derek Cogan , Neil Moss , Christopher Ronald Sarko , Samantha Jayne Bamford , Pui Leng Loke , Spencer Charles R. Napier , Heather Tye , Mark Whittaker
发明人: Derek Cogan , Neil Moss , Christopher Ronald Sarko , Samantha Jayne Bamford , Pui Leng Loke , Spencer Charles R. Napier , Heather Tye , Mark Whittaker
IPC分类号: A61K31/454 , C07D401/14 , C07D403/04 , A61K31/4545 , A61K31/506 , A61K31/4439 , A61K31/4178 , A61P9/00 , A61P9/12 , A61P25/06 , A61P15/10 , A61P29/00 , A61P1/00 , A61P25/24 , A61P25/22 , A61P25/28 , A61P25/16 , A61P11/06 , A61P11/00 , A61P13/08 , A61P25/00 , C07D401/04
CPC分类号: C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: Disclosed are Serotonin 5-HT2B receptor inhibitors of the formula I. Also disclosed are methods of making and methods of using these compounds.
摘要翻译: 公开了式I的5-羟色胺5-HT 2B受体抑制剂。还公开了制备方法和使用这些化合物的方法。
-
公开(公告)号:US06852717B2
公开(公告)日:2005-02-08
申请号:US10143322
申请日:2002-05-10
申请人: Pier Francesco Cirillo , Daniel R. Goldberg , Abdelhakim Hammach , Neil Moss , John Robinson Regan
发明人: Pier Francesco Cirillo , Daniel R. Goldberg , Abdelhakim Hammach , Neil Moss , John Robinson Regan
IPC分类号: C07D251/46 , A61K31/351 , A61K31/366 , A61K31/415 , A61K31/4439 , A61K31/505 , A61K31/506 , A61K31/53 , A61K31/5377 , A61P1/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P13/12 , A61P17/00 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/02 , A61P19/10 , A61P25/00 , A61P25/28 , A61P29/00 , A61P37/02 , A61P37/06 , A61P39/02 , A61P43/00 , C07D213/38 , C07D213/40 , C07D213/63 , C07D231/38 , C07D231/40 , C07D239/34 , C07D239/46 , C07D239/47 , C07D239/52 , C07D239/56 , C07D251/16 , C07D251/22 , C07D309/10 , C07D309/12 , C07D309/36 , C07D309/38 , C07D401/12 , C07D403/12 , C07D405/12 , C07D417/12 , C07D413/04 , C07D253/02
CPC分类号: C07D403/12 , A61K31/505 , A61K31/506 , C07D213/38 , C07D213/63 , C07D231/40 , C07D239/34 , C07D239/46 , C07D239/47 , C07D251/16 , C07D251/22 , C07D309/12 , C07D309/38 , C07D401/12 , C07D405/12 , C07D417/12
摘要: Disclosed are compounds useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.
摘要翻译: 公开了用于治疗涉及炎症的疾病或病理状况的药物组合物中的化合物,例如慢性炎性疾病。 还公开了制备这些化合物的方法。
-
公开(公告)号:US06765009B2
公开(公告)日:2004-07-20
申请号:US10120028
申请日:2002-04-10
申请人: Pier Francesco , Daniel R. Goldberg , Abdelhakim Hammach , Neil Moss , Kristen Mueller , John Robinson Regan
发明人: Pier Francesco , Daniel R. Goldberg , Abdelhakim Hammach , Neil Moss , Kristen Mueller , John Robinson Regan
IPC分类号: C07D23934
CPC分类号: C07D213/79 , C07D213/63 , C07D213/81 , C07D239/34 , C07D265/32 , C07D309/36
摘要: Disclosed are novel 1,4-disubstituted benzo-fused compounds wherein G, X, L, Q, n and Y are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.
摘要翻译: 公开了其中G,X,L,Q,n和Y如本文所定义的新的1,4-二取代的苯并稠合化合物。 该化合物可用于治疗涉及炎症的疾病或病理状况的药物组合物,例如慢性炎性疾病。 还公开了制备这些化合物的方法。
-
公开(公告)号:US07115644B2
公开(公告)日:2006-10-03
申请号:US10654452
申请日:2003-09-03
申请人: Antonio Jose del Moral Barbosa, Jr. , Daniel R. Goldberg , Abdelhakim Hammach , Pingrong Liu , Neil Moss , Mark Stephen Ralph , Gregory Paul Roth , Christopher Ronald Sarko , Fariba Soleymanzadeh , Andre White
发明人: Antonio Jose del Moral Barbosa, Jr. , Daniel R. Goldberg , Abdelhakim Hammach , Pingrong Liu , Neil Moss , Mark Stephen Ralph , Gregory Paul Roth , Christopher Ronald Sarko , Fariba Soleymanzadeh , Andre White
IPC分类号: A61K31/4184 , C07D235/26
CPC分类号: C07D231/12 , C07D233/56 , C07D235/26 , C07D249/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D417/04 , C07D471/10 , C07D491/10
摘要: Disclosed are benzimidazolone compounds of formulas (I) & (II):wherein R1, R2, R3, R4, R5, X, L, m, n and t are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds
摘要翻译: 公开了式(I)和(II)的苯并咪唑酮化合物:其中R 1,R 2,R 3,R 4 R 5,X 5,L,m,n和t在本文中定义。 该化合物抑制涉及炎症过程的细胞因子的产生,因此可用于治疗涉及诸如慢性炎性疾病的炎症的疾病和病理状况。 还公开了制备这些化合物的方法和包含这些化合物的药物组合物
-
公开(公告)号:US07279475B2
公开(公告)日:2007-10-09
申请号:US10940898
申请日:2004-09-14
申请人: Pier Francesco Cirillo , Abdelhakim Hammach , Victor Kamhi , Neil Moss , Paul S Riska , Christopher Pargellis
发明人: Pier Francesco Cirillo , Abdelhakim Hammach , Victor Kamhi , Neil Moss , Paul S Riska , Christopher Pargellis
IPC分类号: A61K31/5377 , A61K31/496 , C07D413/06 , C07D403/06
CPC分类号: C07D249/08 , C07D231/12 , C07D233/56 , C07D239/34 , C07D239/47 , C07D239/52 , C07D401/12 , C07D405/12
摘要: Disclosed are compounds of formula(I): wherein R1, R2, W and X of formula(I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
摘要翻译: 公开了式(I)的化合物:其中式(I)的R 1,R 2,W和X如本文所定义。 该化合物抑制涉及炎症过程的细胞因子的产生,因此可用于治疗涉及诸如慢性炎性疾病的炎症的疾病和病理状况。 还公开了制备这些化合物的方法和包含这些化合物的药物组合物。
-
公开(公告)号:US5672586A
公开(公告)日:1997-09-30
申请号:US666732
申请日:1996-06-18
申请人: Jean Andre Gauthier , Neil Moss
发明人: Jean Andre Gauthier , Neil Moss
IPC分类号: A61K38/00 , A61K31/505 , A61K31/52 , A61P31/12 , A61P31/22 , C07C237/22 , C07K14/035 , A61K38/04 , A61K38/07 , C07K5/00
CPC分类号: C07C237/22 , C07K14/005 , A61K38/00 , C12N2710/16622
摘要: Disclosed herein are compounds of the formula ##STR1## wherein R.sup.1 is hydrogen or (1-4C) alkyl, R.sup.2 is (1-4C) alkyl or a therapeutically acceptable salt thereof. The compounds are useful for treating herpes infections.
摘要翻译: 本文公开的是下式的化合物:其中R 1是氢或(1-4C)烷基,R 2是(1-4C)烷基或其治疗上可接受的盐。 该化合物可用于治疗疱疹感染。
-
19.
公开(公告)号:US5484771A
公开(公告)日:1996-01-16
申请号:US219600
申请日:1994-03-29
申请人: Pierre L. Beaulieu , Robert Deziel , Neil Moss
发明人: Pierre L. Beaulieu , Robert Deziel , Neil Moss
IPC分类号: A61K38/00 , A61P31/12 , A61P31/22 , C07K1/02 , C07K1/113 , C07K5/06 , C07K5/072 , C07K5/08 , C07K5/093 , A61K38/06
CPC分类号: C07K5/0819 , C07K5/06113 , A61K38/00
摘要: Described herein are peptide derivatives of the formula R.sup.1 NH--CO--Q--C(O)--NR.sup.2 --CH[CH.sub.2 C(O)--Y]--C(O)--NH--CH[CR.sup.3 (R.sup.4)--COOH]--C(W)--NH--CHR.sup.5 --Z wherein R.sup.1 is an optionally substituted alkyl or optionally substituted phenylalkyl, R.sup.2 is hydrogen or alkyl, R.sup.3 and R.sup.4 each independently is hydrogen or alkyl, or R.sup.3 and R.sup.4 are joined to form a cycloalkyl. R.sup.5 is alkyl, cycloalkyl or (cycloalkyl)alkyl, Q is a divalent radical, for example, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH-- or 1,2-cyclohexanediyl, which serves as a two carbon spacer. W is oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubsdtuted ammo, and Z is a terminal unit, for example, hydrogen, COOH or CH.sub.2 OH. The derivatives are useful for treating herpes infections.
摘要翻译: 本文描述的是式R1NH-CO-QC(O)-NR2-CH [CH2C(O)-Y] -C(O)-NH-CH [CR3(R4)-COOH] -C(W)的肽衍生物 -NH-CHR 5 -Z,其中R 1是任选取代的烷基或任选取代的苯基烷基,R 2是氢或烷基,R 3和R 4各自独立地是氢或烷基,或者R 3和R 4连接形成环烷基。 R 5是烷基,环烷基或(环烷基)烷基,Q是二价基团,例如-CH 2 CH 2 - , - CH = CH-或1,2-环己二基,其用作二碳间隔基。 W是氧代或硫代,Y是例如烷氧基或单取代或未取代的氨基,Z是末端单元,例如氢,COOH或CH 2 OH。 该衍生物可用于治疗疱疹感染。
-
公开(公告)号:US06916814B2
公开(公告)日:2005-07-12
申请号:US10187942
申请日:2002-07-01
申请人: Neil Moss , John Robinson Regan
发明人: Neil Moss , John Robinson Regan
IPC分类号: C07D231/40 , A61K31/216 , A61K31/415 , A61K31/4155 , A61K31/435 , A61K31/4439 , A61K31/5377 , A61K31/541 , A61P1/18 , A61P7/00 , A61P9/00 , A61P9/04 , A61P9/10 , A61P11/00 , A61P15/00 , A61P19/02 , A61P19/08 , A61P25/28 , A61P27/02 , A61P29/00 , A61P35/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/12 , C07D413/12 , A61K31/535 , A61K31/425 , A61K31/47 , A61K31/495 , A61K31/525
CPC分类号: A61K31/5377 , A61K31/216 , A61K31/415 , A61K31/435
摘要: Disclosed are methods of treating certain cytokine mediated diseases or conditions using novel aromatic heterocyclic compounds of the formula(I) wherein Ar1,Ar2,L,Q and X are described herein.
摘要翻译: 公开了使用新的式(I)芳族杂环化合物治疗某些细胞因子介导的疾病或病症的方法,其中描述了Ar 1,Ar 2,L 2,Q 3和X 2 这里。
-
-
-
-
-
-
-
-
-